GRAIL to Announce Second Quarter 2024 Financial Results
Rhea-AI Summary
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced it will release its second quarter 2024 financial results on Tuesday, August 13, 2024, after market close. The company will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to discuss the results and business progress.
Investors and interested parties can access the live webcast and recorded replay through the investor relations section of GRAIL's website at investors.grail.com. Registration for the teleconference is available at https://grail-q2-financial-results-2024.open-exchange.net/. Participants are advised to register and join the webcast at least ten minutes before the scheduled start time to ensure timely connection.
Positive
- GRAIL is maintaining transparency by hosting a public webcast and conference call to discuss financial results
- The company provides easy access to financial information through its investor relations website
Negative
- None.
News Market Reaction
On the day this news was published, GRAL gained 8.19%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Second Quarter 2024 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q2-financial-results-2024.open-exchange.net/.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-second-quarter-2024-financial-results-302211341.html
SOURCE GRAIL, Inc.
FAQ
When will GRAIL (GRAL) release its Q2 2024 financial results?
What time is GRAIL's Q2 2024 earnings call scheduled for?
How can investors access GRAIL's Q2 2024 earnings webcast?
What is the registration link for GRAIL's Q2 2024 financial results teleconference?
